Avin Maroof

MD specialist in Rheumatology and Medical Rehabilitation

[Avin Maroof @MaroofAvin]

A proud moment ✨ Honored to be part of this remarkable project and to work with such an inspiring team under the leadership of Prof. @Nellziade .Together, we are generating evidence to make a real difference for patients & clinical practice in our region. #eular26 #ARCH_ArLAR

[Nelly ZIADE 🍀 @Nellziade]

Thrilled to present, for the first time, reassuring fertility data in axSpA at #EULAR2026 🎤

First data from the #PROSPA study in 15 Arab countries

Great energy & feedback in the room ✨
Thank you to the PROSPA team 🙏
The best is yet to come! 🌟

#ARCH_ArLAR
@ArLARheumatolog

[Nelly ZIADE 🍀 @Nellziade]

One of the highlights of #EULAR2026 for me:

♀️The "This Is a Woman's World" session

I recapped 8 must-know abstracts (including our work from ARCH_ArLAR) in a new @RheumNow video🎬

https://t.co/3jwJIegGg4 via @YouTube

@ArLARheumatolog

[Nelly ZIADE 🍀 @Nellziade]

🔥 TOGETHER-PsA (OP069) #EULAR2026 #EULARbest
Ixekizumab + Tirzepatide vs IXE alone in PsA with obesity/overweight:
✅ Primary endpoint (ACR50 + ≥10% wt loss at W36): 31.7% vs. 0.8% (p<0.001)
✅ ACR50: 33.5% vs. 20.4%
✅ MDA: 26.3% vs. 15.3% (p=0.026)

@rheumnow @DrLauraCoates

[Nelly ZIADE 🍀 @Nellziade]

🧬 Does spine vs knee enthesis differ immunologically?

Translational scRNAseq study: YES!

Spine produces more IL-23 but shows attenuated IL-17 response vs knee

#POS0084 #EULAR2026 @RheumNow

[Nelly ZIADE 🍀 @Nellziade]

💉 Does bimekizumab work in real-world PsA?

YES - EuroSpA: 76% retention at 6months
46% DAPSA LDA in 787pts across 12 registries

#OP0185 #EULAR2026 @RheumNow

[Nelly ZIADE 🍀 @Nellziade]

🦴 Does TNF-driven iron overload fuel bone formation in r-axSpA?

Translational study: Iron accumulates in fibroblasts, driving ECM & osteophytes

#POS0080 #EULAR2026 @RheumNow

[Nelly ZIADE 🍀 @Nellziade]

🤰What happens to RA disease activity during pregnancy?

🔴 Most remain stable
🔴 70% with high disease activity at baseline improve
🔴 20% flare again post-partum

✨ACPA+ improve more
✨ Better outcomes after 2016 (after modern treatments)

OP0242 #EULAR2025 @rheumnow

[Nelly ZIADE 🍀 @Nellziade]

⏰ The question rheumatologists keep asking: Does early axSpA diagnosis reduce long-term spinal damage?

Answer from the SCQM registry (n=376): Early diagnosis linked to 3.85 fewer mSASSS points long-term, esp. in HLA-B27+ males

#POS0191 #EULAR2026 @RheumNow

[Nelly ZIADE 🍀 @Nellziade]

Live vaccinations in infants antenatally exposed to bDMARDs
⬇️⬇️
#WIN session @lauraandreoli80

#EULAR2026 @RheumNow

[Nelly ZIADE 🍀 @Nellziade]

��� Do 2025 ASAS-SPARTAN criteria classify fewer real-world axSpA patients?

Data from the RABBIT-SpA registry (n=2,236) confirms:
67% vs 73% with 2009 criteria

Clinical arm rarely fulfilled

#POS0190 #EULAR2026 @RheumNow

[Antoni Chan MD (Prof) @synovialjoints]

Izokibep (novel small IL-17A inhibitor, 18.6 kDa) maintained efficacy to Week 52 in active #PsA with ~50% of patients achieving ACR50 and nearly half reaching MDA. Sustained durable response with no new safety signals Abstr#OP073 @RheumNow #EULAR2026

[Nelly ZIADE 🍀 @Nellziade]

How many patients from real life fulfill the inclusion criteria of clinical trials?

Not so many ⬇️

#HOT session Pr Oliver Distler

#EULAR2026 @RheumNow

[Nelly ZIADE 🍀 @Nellziade]

🔍 Are 2025 ASAS-SPARTAN criteria valid in early axSpA?

SPACE cohort (n=669):

HIGH specificity (97.5%) but LOWER sensitivity (60%) vs 2009 criteria (83%)

#OP0239 #EULAR2026 @RheumNow

[Nelly ZIADE 🍀 @Nellziade]

💉 Add tirzepatide to biologics in obese #PsA?

#POS0050: Yes! Propensity score-matched study (n=93):
better PROs, HAQ & PASI at 6 months

#EULAR2026 @RheumNow
@vincevenerito

[Nelly ZIADE 🍀 @Nellziade]

🔍 What defines a positive MRI for #axSpA?

SPARTAN-SSR consensus (n=1,050):
BME≥3 slices or 2/3 lesions in ≥3 SIJ quadrants

#OP0100 #EULAR2026 @RheumNow

[Nelly ZIADE 🍀 @Nellziade]

🔍 Is #axSpA overdiagnosed locally?

IMPROVE-axSpA prosp study (n=969):
Yes!

Only 54% locally confirmed centrally

#OP0105 #EULAR2026 @RheumNow

[Nelly ZIADE 🍀 @Nellziade]

#EULAR2026 General Assembly is ON!

Record-breaking 5'705 abstracts from 102 countries

187 scientific sessions ahead

@rheumnow

[ASAS @Official_ASAS]

Great ASAS Annual Workshop 2026, held on January 16–17 in Athens, Greece 🇬🇷
Two days of excellent science, collaboration, and advances in spondyloarthritis research.
#ASAS #Spondyloarthritis #AxSpA #Rheumatology

[Avin Maroof @MaroofAvin]

New multi-centric ArCH-#ArLAR publication!

📌 Key finding: ~1 in 5 PsA patients in Arab countries screened positive for FM.

✨Proud to be part of this distinguished research and grateful to all the esteemed co-authors for their invaluable contributions.

#fibromyalgia #PsA

[Nelly ZIADE 🍀 @Nellziade]

About #Multidisciplinarity ...

Dr Ihsane Hmamouchi talking about Multidisciplinary Approach to Migrant #Rheumatology Care

#quotes
#EULAR2025
#Invitedspeaker
#outofthebox
@RheumNow
@epirheum